BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8198969)

  • 1. Functional role of IL-2 receptors on tumour-infiltrating lymphocytes.
    Trentin L; Zambello R; Bulian P; Cerutti A; Milani A; Pirone E; Nitti D; Agostini C; Semenzato G
    Br J Cancer; 1994 Jun; 69(6):1046-51. PubMed ID: 8198969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
    Trentin L; Zambello R; Bulian P; Cerutti A; Enthammer C; Cassatella M; Nitti D; Lise M; Agostini C; Semenzato G
    Br J Cancer; 1995 Feb; 71(2):240-5. PubMed ID: 7841036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.
    Yoong KF; Adams DH
    Br J Cancer; 1998 Apr; 77(7):1072-81. PubMed ID: 9569042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumour infiltrating lymphocytes.
    Maeurer MJ; Walter W; Martin D; Zitvogel L; Elder E; Storkus W; Lotze MT
    Scand J Immunol; 1997 Feb; 45(2):182-92. PubMed ID: 9042431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.
    Ferrarini M; Heltai S; Pupa SM; Mernard S; Zocchi R
    J Natl Cancer Inst; 1996 Apr; 88(7):436-41. PubMed ID: 8618235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a functional p75 interleukin-2 receptor on lung lymphocytes from patients with human immunodeficiency virus type 1 (HIV-1) infection.
    Zambello R; Trentin L; Benetti R; Cipriani A; Crivellaro C; Cadrobbi P; Agostini C; Semenzato G
    J Clin Immunol; 1992 Sep; 12(5):371-80. PubMed ID: 1430108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Facco M; Trentin L; Sancetta R; Tassinari C; Perin A; Milani A; Pizzolo G; Rodeghiero F; Agostini C; Meazza R; Ferrini S; Semenzato G
    Blood; 1997 Jan; 89(1):201-11. PubMed ID: 8978293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes.
    Ditonno P; Tso CL; Sakata T; deKernion JB; Belldegrun A
    Urol Res; 1992; 20(3):205-10. PubMed ID: 1615582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies.
    Nouri AM; dos Santos AV; Crosby D; Oliver RT
    Br J Cancer; 1991 Dec; 64(6):996-1000. PubMed ID: 1764393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and cytolytic activity of mouse tumor-bearer splenocytes and tumor-infiltrating lymphocytes from K-1735 melanoma metastases following anti-CD3, interleukin-2, and tumor necrosis factor-alpha combination immunotherapy.
    Yang SC; Fry KD; Grimm EA; Roth JA
    J Immunother (1991); 1991 Oct; 10(5):326-35. PubMed ID: 1790140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human melanoma cells express a functional interleukin-2 receptor.
    Plaisance S; Rubinstein E; Alileche A; Han DS; Sahraoui Y; Mingari MC; Bellomo R; Rimoldi D; Colombo MP; Jasmin C
    Int J Cancer; 1993 Aug; 55(1):164-70. PubMed ID: 8344747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro enhanced cytotoxicity of tumor-infiltrating lymphocytes transfected with tumor necrosis factor-related apoptosis-inducing ligand and/or interleukin-2 gene in human renal cell carcinoma.
    Tian JQ; Wang ZP; Rodriguez R; Fu JS; Lu JZ; Ma BL
    Urology; 2006 May; 67(5):1093-8. PubMed ID: 16635513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues.
    Hsu SM; Tseng CK; Hsu PL
    Am J Pathol; 1990 Apr; 136(4):735-44. PubMed ID: 1691591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Arii K; Noguchi K
    Biotherapy; 1992; 4(1):9-15. PubMed ID: 1543654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
    Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
    J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.